Method of treating proliferative disorders and other pathological conditions mediated by Bcr-Abl, c-Kit, DDR1, DDR2 or PDGF-R kinase activity | Patent Number 09061029
US 09061029 B2Filled DateNov 17, 2010
Priority DateNov 17, 2009
Publication DateNov 15, 2012
Expiration DateNov 16, 2029
Inventor/ApplicantsOphelia Yin
Neil Gallagher
Neil Gallagher
ExaminesHENLEY III, RAYMOND J
Art Unit1629
Technology Center1600
Assignments
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge ProgramEmpower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.